肺段切除术与肺叶切除术对早期肺癌患者非肺癌死亡的影响
研究纳入2008年1月至2018年12月间因临床0–I期原发性肺癌行肺叶或肺段切除、术后无复发证据的1385例患者,分析非肺癌死亡(NLCD)的危险因素。多因素分析显示年龄≥65岁、吸烟指数≥600、BMI≤18.5 kg/m2、间质性肺炎、预测肺活量百分比≤9.4%及肺叶切除为NLCD危险因素;倾向评分匹配后肺段切除组5年总生存优于肺叶切除组。
要点
- 多因素分析显示肺叶切除是非肺癌死亡的危险因素之一。
- 倾向评分匹配后肺段切除5年OS 94.6% vs 肺叶切除90.4%(P=0.027)。
- 高合并症患者肺段切除5年OS优于肺叶切除(92.8% vs 87.8%,P=0.016),低合并症者两组无差异(98.5% vs 97.4%,P=0.867)。
核心结论
- 肺叶切除与肺段切除对非肺癌死亡的影响取决于患者合并症的严重程度。
研究设计与样本
- 单中心研究,纳入2008年1月至2018年12月间因临床0–I期原发性肺癌行肺叶或肺段切除、术后无复发证据的1385例患者。
- 采用多因素logistic回归分析非肺癌死亡的危险因素,并用log-rank检验比较低合并症与高合并症患者中肺叶切除与肺段切除的总生存。
- 采用倾向评分匹配比较肺段切除与肺叶切除患者的5年总生存。
主要发现
- 非肺癌死亡组(n=126)接受肺叶切除的比例高于无复发生存组(n=1259)。
- 多因素分析显示年龄≥65岁、吸烟指数≥600、BMI≤18.5 kg/m2、间质性肺炎、预测肺活量百分比≤9.4%及肺叶切除是非肺癌死亡的危险因素。
- 倾向评分匹配后,肺段切除组5年总生存优于肺叶切除组(94.6% vs 90.4%,P=0.027)。
- 高合并症患者中,肺段切除组5年总生存优于肺叶切除组(92.8% vs 87.8%,P=0.016)。
- 低合并症患者中,肺段切除与肺叶切除5年总生存无差异(98.5% vs 97.4%,P=0.867)。
关键数值与推荐
- 高合并症定义为具有以下风险中≥2项:年龄≥65岁、吸烟指数≥600、BMI≤18.5 kg/m2、Charlson合并症指数≥1、预测肺活量百分比≤96.4%。
- 倾向评分匹配后5年总生存:肺段切除组94.6% vs 肺叶切除组90.4%(P=0.027)。
- 高合并症患者5年总生存:肺段切除组92.8% vs 肺叶切除组87.8%(P=0.016)。
- 低合并症患者5年总生存:肺段切除组98.5% vs 肺叶切除组97.4%(P=0.867)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to analyse the risk of death from non-lung cancer after segmentectomy or lobectomy for early-stage lung cancer. METHODS: A total of 1385 patients underwent lobectomy or segmentectomy for clinical stage 0-I primary lung cancer, with no evidence of recurrence after surgery, between January 2008 and December 2018. Risk factors for non-lung cancer deaths (NLCD) were analysed using multivariable logistic regression analysis. The overall survival (OS) of patients with low and high comorbidities who underwent lobectomy and segmentectomy was compared using a log-rank test. RESULTS: Patients with NLCD (n = 126) were more likely to have undergone lobectomy than patients with non-recurrence survival (n = 1259). Multivariable analysis revealed that age (≥65 years), smoking index (≥600), body mass index (≤18.5 kg/m2), interstitial pneumonia, values for percentage of predicted vital capacity (≤9.4%) and lobectomy were risk factors for NLCD. Patients who underwent segmentectomy had significantly better 5-year OS than those who underwent lobectomy, after propensity score matching (94.6% vs 90.4%, P = 0.027). Patients with high comorbidities (patients with ≥2 of the following risks: age ≥65 years, smoking index ≥600, body mass index ≤18.5 kg/m2, Charlson Comorbidity Index ≥1, values for percentage of predicted vital capacity ≤96.4%) who underwent segmentectomy had a better 5-year OS than those who underwent lobectomy (92.8% vs 87.8%, P = 0.016). However, there was no difference in 5-year OS between segmentectomy and lobectomy in patients with low comorbidities (98.5% vs 97.4%, P = 0.867). CONCLUSIONS: The impact of lobectomy and segmentectomy on NLCD depends on the extent of the patients' comorbidities.
引用
- Isaka T, Ito H, Yokose T, et al. Impact of segmentectomy and lobectomy on non-lung cancer death in early-stage lung cancer patients. Eur J Cardiothorac Surg. 2022. PMID: 36124963. doi:10.1093/ejcts/ezac458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。